• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » The CenterWatch Monthly, March 2012

The CenterWatch Monthly, March 2012

March 1, 2012
CenterWatch Staff

Living in a post-M&A world of CROs

The CRO industry has been reshaped during the past year by a wave of acquisitions. Large-scale mergers, led by INC Research and inVentiv, have given mid-tier CROs the global scale needed to compete against their rivals for the biggest outsourcing opportunities. At the same time, the industry has consolidated as major CROs continue to make small, strategic acquisitions that can fill gaps in their…

 

Sites struggle with burden, blessing of multiple technologies

With pressure from sponsors and CROs to perform more efficiently and effectively, sites must depend on a variety of system requirements while keeping pace with evolving technology solutions. Sites typically adapt to the technology needs of sponsors and CROs, juggling multiple system requirements across multiple clinical trials, which results in…

 

Eye on Emergent

To reduce development risks and time before products come to market, Emergent BioSolutions uses an acquisition and licensing strategy to procure biodefense and commercial product candidates capable of stimulating a prophylactic or therapeutic immune response...

 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing